These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26194926)

  • 21. [Imaging diagnosis of Alzheimer's disease].
    Mänz C; Reimold M; Bender B; Bares R; Ernemann U; Horger M
    Rofo; 2012 Dec; 184(12):1079-82. PubMed ID: 23212812
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.
    Murray ME; Lowe VJ; Graff-Radford NR; Liesinger AM; Cannon A; Przybelski SA; Rawal B; Parisi JE; Petersen RC; Kantarci K; Ross OA; Duara R; Knopman DS; Jack CR; Dickson DW
    Brain; 2015 May; 138(Pt 5):1370-81. PubMed ID: 25805643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 100-year update on Alzheimer's disease and related disorders.
    Reiman EM
    J Clin Psychiatry; 2006 Nov; 67(11):1782-3. PubMed ID: 17196060
    [No Abstract]   [Full Text] [Related]  

  • 24. William R. Markesbery, MD: A 7th generation Kentuckian.
    Danner D; Thomason PC
    Neuromolecular Med; 2011 Mar; 13(1):17-8. PubMed ID: 20652769
    [No Abstract]   [Full Text] [Related]  

  • 25. Memories of Dr. William R. Markesbery.
    Lovell MA
    Neuromolecular Med; 2011 Mar; 13(1):15-6. PubMed ID: 20544307
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
    Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
    Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nick Fox: aiming to prevent Alzheimer's disease.
    Kirby T
    Lancet Neurol; 2012 Feb; 11(2):128. PubMed ID: 22265209
    [No Abstract]   [Full Text] [Related]  

  • 28. Biopsy support for the validity of Pittsburgh compound B positron emission tomography with a twist.
    Klunk WE
    Arch Neurol; 2008 Oct; 65(10):1281-3. PubMed ID: 18852340
    [No Abstract]   [Full Text] [Related]  

  • 29. Alzheimer's imaging agents struggle to find a market outside trials.
    Williams SC
    Nat Med; 2013 Dec; 19(12):1551. PubMed ID: 24309640
    [No Abstract]   [Full Text] [Related]  

  • 30. Bengt Winblad: coaching the team in Alzheimer's disease.
    Mayor S
    Lancet Neurol; 2009 Jun; 8(6):514. PubMed ID: 19446272
    [No Abstract]   [Full Text] [Related]  

  • 31. William R. Markesbery, M.D.: mentor and friend.
    Scheff SW
    Neuromolecular Med; 2011 Mar; 13(1):3-5. PubMed ID: 20544306
    [No Abstract]   [Full Text] [Related]  

  • 32. Microbleeds in atypical presentations of Alzheimer's disease: a comparison to dementia of the Alzheimer's type.
    Whitwell JL; Kantarci K; Weigand SD; Lundt ES; Gunter JL; Duffy JR; Strand EA; Machulda MM; Spychalla AJ; Drubach DA; Petersen RC; Lowe VJ; Jack CR; Josephs KA
    J Alzheimers Dis; 2015; 45(4):1109-17. PubMed ID: 25649655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological characters of [18F]O-FEt-PIB in a rat model of Alzheimer's disease using micro-PET imaging.
    Zheng MQ; Yin DZ; Zhang L; Lei B; Cheng DF; Cai HC; Han YJ; Wu MX; Zhang H; Wang J
    Acta Pharmacol Sin; 2008 May; 29(5):548-54. PubMed ID: 18430362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overview: the long and winding road to understanding Alzheimer's disease.
    Herz J
    Neuron; 2007 Feb; 53(4):477-9. PubMed ID: 17296548
    [No Abstract]   [Full Text] [Related]  

  • 35. Reisa Sperling: acting out, Alzheimer's in.
    Holmes D
    Lancet Neurol; 2012 Mar; 11(3):212. PubMed ID: 22341031
    [No Abstract]   [Full Text] [Related]  

  • 36. Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2.
    Jack CR; Barnes J; Bernstein MA; Borowski BJ; Brewer J; Clegg S; Dale AM; Carmichael O; Ching C; DeCarli C; Desikan RS; Fennema-Notestine C; Fjell AM; Fletcher E; Fox NC; Gunter J; Gutman BA; Holland D; Hua X; Insel P; Kantarci K; Killiany RJ; Krueger G; Leung KK; Mackin S; Maillard P; Malone IB; Mattsson N; McEvoy L; Modat M; Mueller S; Nosheny R; Ourselin S; Schuff N; Senjem ML; Simonson A; Thompson PM; Rettmann D; Vemuri P; Walhovd K; Zhao Y; Zuk S; Weiner M
    Alzheimers Dement; 2015 Jul; 11(7):740-56. PubMed ID: 26194310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revised criteria for diagnosis of Alzheimer's disease: National Institute on Aging-Alzheimer's Association diagnostic guidelines for Alzheimer's disease.
    Khachaturian ZS
    Alzheimers Dement; 2011 May; 7(3):253-6. PubMed ID: 21575869
    [No Abstract]   [Full Text] [Related]  

  • 38. Imaging beta-amyloid burden in aging and dementia.
    Linazasoro G
    Neurology; 2008 Apr; 70(18):1649; author reply 1650. PubMed ID: 18443321
    [No Abstract]   [Full Text] [Related]  

  • 39. Positron emission tomography with Pittsburgh compound B in diagnosis of early stage Alzheimer's disease.
    Jia J; Sun B; Guo Z; Zhang J; Tian J; Tang H; Wang L
    Cell Biochem Biophys; 2011 Jan; 59(1):57-62. PubMed ID: 20714824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspective on the Alzheimer's disease neuroimaging initiative: progress report and future plans.
    Khachaturian ZS
    Alzheimers Dement; 2010 May; 6(3):199-201. PubMed ID: 20451867
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.